US Patent Issued to Suzhou Forlong Biotechnology on Sept. 8 for "Development and use of interleukin 15 mutant polypeptide" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,230, issued on Sept. 8, was assigned to Suzhou Forlong Biotechnology Co. Ltd. (Jiangsu, China).

"Development and use of interleukin 15 mutant polypeptide" was invented by En Ji (Jiangsu, China) and Chunyu Wang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present application are an IL-15 mutant polypeptide, and a preparation method therefor and the use thereof. Further provided are a nucleic acid encoding the IL-15 mutant polypeptide, a vector containing the nucleic acid, and a host cell."

The patent was filed on May 23, 2022, under Application No. 18/564,329.

*For further information, including images, charts and ...